-+ 0.00%
-+ 0.00%
-+ 0.00%

Xylem Lowers FY2026 Adj EPS Guidance from $5.55-$5.70 to $5.40-$5.45 vs $5.66 Est; Lowers FY2026 Sales Guidance from $9.200B to $8.950B vs $9.191B Est

Benzinga·10/27/2026 10:55:32
Listen to the news
Xylem (NYSE:XYL) lowers FY2026 Adj EPS guidance from $5.55-$5.70 to $5.40-$5.45 vs $5.66 analyst estimate. Lowers FY2026 sales outlook from $9.200 billion to $8.950 billion vs $9.191 billion estimate.